# US 2021/0259924 A1 · Devices and methods for providing hydrolyzed lipids

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0259924 A1
- Document ID: US20210259924A1
- Status: Published application
- Kind: A1
- Application number: 17/317,374
- Filed: 2021-05-11
- Published: 2021-08-26
- Earliest claimed: 2017-08-17
- Assignees: Alcresta Therapeutics, Inc.
- Applicants: Alcresta Therapeutics, Inc.
- Inventors: Eric FIRST; David Widom
- Web page: https://patentgrep.com/patent/US20210259924A1

## CPC

- A61J 9/005: {Non-rigid or collapsible feeding-bottles}
- A23L 33/115: Fatty acids or derivatives thereof; Fats or oils
- A61J 1/2003: {Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting}
- A61J 1/2089: {Containers or vials which are to be joined to each other in order to mix their contents (combinations of vial and syringe for mixing their contents A61J1/2096)}
- A61J 1/2093: {Containers having several compartments for products to be mixed}
- A61J 15/0003: {Nasal or oral feeding-tubes, e.g. tube entering body through nose or mouth}
- A61J 15/0026: {Parts, details or accessories for feeding-tubes (external tubes from medical containers to a connector outside of the body A61M39/08)}
- A23L 33/00: Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A61J 1/067: {Flexible ampoules, the contents of which are expelled by squeezing}
- A61J 7/0053: {Syringes, pipettes or oral dispensers}
- A61K 9/00: Medicinal preparations characterised by special physical form {(nuclear magnetic resonance contrast preparations or magnetic resonance imaging contrast preparations A61K49/18; preparations containing radioactive substances A61K51/12)}
- A61J: CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Exemplary embodiments of the disclosure may be drawn to a device having a vessel configured to contain a source of lipids and a chamber fluidly connected to an outlet of the vessel. The chamber may contain immobilized lipase positioned within a flow path in the chamber along which the lipids flow when released from the vessel into the chamber. The device may also include an outlet through which the lipids flow after passing through the chamber.

## Claims

### Claim at position 1

1-23. (canceled)

### Claim 24

A device comprising:
a vessel configured to store a flowable lipid;
a chamber including an inlet and an outlet, wherein the chamber is connected to an opening of the vessel, and wherein the chamber contains lipase; and
one of an interface or an output assembly coupled to the chamber, wherein a flow path extends through an opening in the vessel, through the inlet of the chamber, through the outlet of the chamber, and through the interface or the output assembly;
wherein at least one of an outlet of the interface or the outlet assembly or the opening of the vessel is configured to retain the flowable lipid within the vessel prior to use of the device.

### Claim 25 (depends on 24)

The device of claim 24, wherein the vessel contains the flowable lipid.

### Claim 26 (depends on 25)

The device of claim 25, wherein the flowable lipid includes at least one of an oil, an infant fortifier, docosahexaenoic acid, or arachidonic acid.

### Claim 27 (depends on 24)

The device of claim 24, wherein the vessel is removably coupled to the chamber.

### Claim 28 (depends on 24)

The device of claim 24, wherein the vessel is prefilled.

### Claim 29 (depends on 24)

The device of claim 24, wherein the vessel is refillable.

### Claim 30 (depends on 24)

The device of claim 24, wherein the flowable lipid is stored under pressure in the vessel.

### Claim 31 (depends on 24)

The device of claim 24, wherein the vessel is compressible.

### Claim 32 (depends on 31)

The device of claim 31, further comprising a compression roller configured to compress the vessel.

### Claim 33 (depends on 24)

The device of claim 24, wherein the chamber comprises a clear or opaque material.

### Claim 34 (depends on 24)

The device of claim 24, wherein the vessel is removably coupled to the chamber.

### Claim 35 (depends on 34)

The device of claim 34, wherein at least one of the outlet of the interface or the outlet assembly or the opening of the vessel is sealed prior to use of the device.

### Claim 36 (depends on 24)

The device of claim 24, further comprising a valve fluidly coupled to the vessel.

### Claim 37 (depends on 24)

The device of claim 24, further comprising a filter coupled to the chamber.

### Claim 38

A device comprising:
a vessel configured to store a flowable lipid;
a chamber including an inlet and an outlet, wherein the chamber is connected to an opening of the vessel, and wherein the chamber contains lipase;
an interface coupled to the chamber, wherein a flow path extends through an opening in the vessel, through the inlet of the chamber, through the outlet of the chamber, and through the interface; and
a connector fluidly coupled to an outlet of the interface, wherein the connector includes:
a first opening;
a second opening; and
a connector flow path extending through the connector from the first opening to the second opening.

### Claim 39 (depends on 38)

The device of claim 38, wherein the first opening of the connector and the second opening of the connector are each configured to fluidly couple to a feeding tube.

### Claim 40 (depends on 38)

The device of claim 38, wherein the connector is shaped as a hollow tube, and wherein the outlet of the interface is fluidly connected to a central region of the connector.

### Claim 41 (depends on 38)

The device of claim 38, wherein the flowable lipid includes two or more different types of lipids.

### Claim 42 (depends on 38)

The device of claim 38, wherein the vessel is compressible.

### Claim 43 (depends on 38)

The device of claim 38, wherein the opening of the vessel is configured to transition from a first configuration in which the flowable lipid is retained within the vessel, and a second configuration in which the flowable lipid is permitted to flow out of the opening of the vessel in response to an application of pressure to at least a portion of the vessel.

### Claim 44

A method of adding hydrolyzed lipids to a liquid prior to ingestion, the method comprising:
causing a source of flowable lipid stored in a vessel of a device to flow out of the vessel and through a chamber of the device that contains lipase in order to hydrolyze the flowable lipid by exposing the flowable lipid to the lipase in the chamber; and
outputting the hydrolyzed lipids from the chamber of the device into the liquid prior to ingestion of the liquid.

### Claim 45 (depends on 44)

The method of claim 44, further comprising filing the vessel with the source of flowable lipid prior to causing the flowable lipid to flow through the chamber.

### Claim 46 (depends on 44)

The method of claim 44, further comprising attaching the device to a feeding system prior to passing the flowable lipid through the chamber.

### Claim 47 (depends on 46)

The method of claim 46, wherein the feeding system is a syringe or container holding a nutritional formula.

### Claim 48 (depends on 44)

The method of claim 44, further comprising detaching the vessel from the device, refilling the vessel with the source of flowable lipid, and reattaching the vessel to the device.

### Claim 49 (depends on 44)

The method of claim 44, wherein the flowable lipid includes two or more different types of lipids.
